Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

RenovoRx (RNXT) Total Liabilities (2024 - 2025)

RenovoRx (RNXT) has disclosed Total Liabilities for 2 consecutive years, with $2.7 million as the latest value for Q4 2025.

  • Quarterly Total Liabilities fell 26.57% to $2.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $2.7 million through Dec 2025, down 26.57% year-over-year, with the annual reading at $2.7 million for FY2025, 26.57% down from the prior year.
  • Total Liabilities hit $2.7 million in Q4 2025 for RenovoRx, down from $3.1 million in the prior quarter.
  • In the past five years, Total Liabilities ranged from a high of $3.6 million in Q4 2024 to a low of $2.7 million in Q4 2025.